| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test | Sarah de Crescenzo | 07/14/20 | San Diego |
| Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown | Sarah de Crescenzo | 03/23/20 | National |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| LabFellows Looks to Become “Operating System” For Life Sciences Cos. | Sarah de Crescenzo | 10/08/19 | San Diego |
| After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease | Sarah de Crescenzo | 02/28/19 | San Diego |
| San Diego Tallies 7 IPOs in Best Year for Market Debuts Since 2014 | Sarah de Crescenzo | 12/15/18 | San Diego |
| Anaplan Ups Estimate For Its IPO Haul; Allogene IPO Raises $288M | Bernadette Tansey | 10/10/18 | San Francisco |
| Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More | Ben Fidler | 09/28/18 | National |
| Equillium Plans IPO to Fund Clinical Trials for Transplant Drug | Sarah de Crescenzo | 09/21/18 | San Diego |
